| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000260646.1 |
Ponatinib |
Brain lower grade glioma |
0.024579107 |
Resistant |
| ENSG00000260646.1 |
Ponatinib |
Liver hepatocellular carcinoma |
0.037154916 |
Resistant |
| ENSG00000260646.1 |
Ponatinib |
Thyroid carcinoma |
0.025366012 |
Sensitive |
